Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Submitted by
admin
on January 31, 2012 - 7:56am
Source:
Yahoo/AP
News Tags:
Allos
Europe
lymphoma
Folotyn
Headline:
Allos Therapeutics asks EU advisory panel to reconsider negative opinion on lymphoma drug
Do Not Allow Advertisers to Use My Personal information
